Browse > Article
http://dx.doi.org/10.5012/bkcs.2012.33.2.651

Enhanced Tumor-targeted Gene Delivery by Immunolipoplexes Conjugated with the Humanized Anti-TAG-72 Fab' Fragments  

Kim, Keun-Sik (Department of Biomedical Laboratory Science, Konyang University)
Park, Yong-Serk (Department of Biomedical Laboratory Science, Yonsei University)
Hong, Hyo-Jeong (Department of Systems Immunology, Kangwon National University)
Kim, Kwang-Pyo (Department of Molecular Biotechnology, Konkuk University)
Lee, Kwang-Hyun (Department of Bioscience and Biotechnology, Konkuk University)
Kim, Dong-Eun (Department of Bioscience and Biotechnology, Konkuk University)
Publication Information
Abstract
Cationic immunoliposomes were prepared by conjugation of Fab' fragments of the recombinant humanized monoclonal antibody (HuCC49) against tumor-associated glycoprotein (TAG)-72 to sterically unilamella liposomes. The cationic immunoliposomes are composed of cationic lipid (O,O'-dimyristyl-N-lysyl aspartate, DMKD), cholesterol, and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethyleneglycol)$_{2000}$] (DPPE-PEG-maleimide) with a molar ratio of 0.5:0.47:0.03. Plasmid DNA was effectively condensed by addition of transferrin (Tf) during the formation of anti-TAG-72 PEG-immunolipoplexes (PILPs). These anti-TAG-72 PILPs were able to adhere to the surface of TAG-72-overexepressing LS174T human colon cancer cells more effectively than conventional liposomes, thereby facilitating gene delivery in vitro. Furthermore, intravenous administration of the anti-TAG-72 PILPs into the tumor-carrying mice exhibited efficient localization of the reporter gene in the tumor tissues.
Keywords
Immunolipoplexes; Humanized monoclonal antibody; Tumor-associated glycoprotein-72; Targeted gene delivery;
Citations & Related Records

Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
  • Reference
1 Maruyama, K. Biosci. Rep. 2002, 22, 251.   DOI   ScienceOn
2 Kashmiri, S. V. S.; Shu, L.; Padlan, E. A.; Milenic, D. E.; Schlom, J.; Hand, P. H. Hybridoma 1995, 14, 461.   DOI   ScienceOn
3 Kim, K. S.; Park, Y. S. Oncol. Res. 2005, 15, 343.   DOI
4 Song, Y. K.; Liu, F.; Liu, D. Hum. Gene Ther. 1997, 8, 1585.   DOI   ScienceOn
5 Shi, N.; Pardridge, W. M. Proc. Natl. Acad. Sci. USA 2000, 97, 7567.   DOI   ScienceOn
6 Kim, K. S.; Lee, Y. K.; Kim, J. S.; Koo, K. H.; Hong, H. J.; Park, Y. S. Cancer Gene. Ther. 2008, 15, 331.   DOI   ScienceOn
7 Xu, L.; Tang, W. H.; Huang, C. C.; Alexander, W.; Xiang, L. M.; Pirollo, K. F.; Rait, A.; Chang, E. H. Mol. Med. 2001, 7, 726.
8 Fenske, D. B.; MacLachlan, I.; Cullis, P. R. Methods Enzymol. 2002, 346, 36.   DOI
9 McCormick, F. Nat. Rev. Cancer 2001, 1, 130.   DOI   ScienceOn
10 Woodle, M. C.; Lasic, D. D. Biophys. Acta. 1992, 1113, 171.   DOI   ScienceOn
11 Pun, S. H.; Davis, M. E. Bioconjugate Chem. 2002, 9, 731.
12 Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Biochim. Biophys. Acta. 1991, 1066, 29.   DOI   ScienceOn
13 Ogris, M.; Brunner, P.; Schuller, S.; Kircheis, R.; Wagner, E. Gene Ther. 1999, 6, 595.   DOI   ScienceOn
14 Audouy, S.; de Leij, L.; Hoekstra, D.; Molema, G. Pharm. Res. 2002, 19, 1599.   DOI   ScienceOn
15 Bendas, G. BioDrugs 2001, 15, 215.   DOI   ScienceOn
16 Sheer, D. G.; Schlom, J.; Cooper, H. L. Cancer Res. 1988, 48, 6811.
17 Maruyama, K.; Takahashi, N.; TAGawa, T.; Nagaike, K.; Iwatsuru, M. FEBS. Letters 1997, 413, 177.   DOI   ScienceOn
18 Mamot, C.; Drummond, D. C.; Nobel, C. O.; Kallab, V.; Guo, Z.; Hong, K. Cancer Res. 2005, 65, 11631.   DOI   ScienceOn